Myeloprolifrative disorders -Chronic Myelogenouse Leukemia - Primary Poly Cythemia ( vira ) - Essential Thrombocythemia - Myelofibrose Myeloid Methaplasia.

Slides:



Advertisements
Similar presentations
TA OGUNLESI (FWACP)1 CHILDHOOD LEUKAEMIA. TA OGUNLESI (FWACP)2 LEUKAEMIA Heterogenous group of malignant disorders Characterised by uncontrolled clonal.
Advertisements

NEOPLASTIC DISORDERS OF THE BONE MARROW
Acute leukemia Mohammed Al-matrafi.
Introduction To Haematological Malignancies
Chronic leukaemias Chronic myelogenous leukaemia Chronic myelogenous leukaemia Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia.
LEUKEMIA—HEMATOLOGY {S1}
Acute Leukaemia Dr. Soheir Adam, MRCPath Assistant Professor Department of Haematology, KAUH.
This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.
WHO CLASSIFICATION OF MYELOID NEOPLASMS 2000  Chronic myeloproliferative disorders (CMPD)  Myelodysplastic / myeloproliferative diseases (MDS/MPD) 
Chapter 17 Chronic Leukemias.
Chronic Leukemia Dr. Rania Alhady Chronic Lymphocytic leukemia (CLL):
Chronic leukemias. Chronic myelogenous (granulocytic) leukemia Is characterized by an unregulated proliferation of myeloid elements in the bone marrow,
Chronic myeloid leukaemia. THE STORY OF CHRONIC MYELOID LEUKAEMIA ‘It is moreover, the same conclusion which Bennett came to in the much-discussed matter.
CHRONIC MYELOID LEUKAEMIA Dr Rosline Hassan Department of Haematology School of Medical Sciences Universiti Sains Malaysia.
Tabuk University Faculty of Applied Medical Sciences
Acute Myeloid Leukemias (AML)
The acute Leukemias are clonal hematopoietic malignant disease that arise from the malignant T r a n s f o r m a t i o n of an early Hematopoietic stem.
MLAB Hematology Keri Brophy-Martinez
C HRONIC LEUKEMIAS. Chronic myelogenous (granulocytic) leukemia Is characterized by an unregulated proliferation of myeloid elements in the bone marrow,
 Myeloid Leukemias are heterogenous group of diseases characterized by infiltration of the blood, bone marrow, and other tissues by neoplastic cells.
CML.  Stem cell disorder  Characterized by myeloproliferation  Well-described clinical course 9 9q+ 22 Ph 22q- BCR ABL BCR ABL Translocation Transcription.
MLAB Hematology Keri Brophy-Martinez Unit 23: CHRONIC MYELOPROLIFERATIVE DISORDERS (MPD)
Chronic Leukemias. CMLCML CLLCLL CML A clonal disease results from an acquired genetic change in a pluri-potential hemopoietic stem cell within the BM.
Myeloproliferative disorders Dr. Tariq Roshan PPSP Department of Hematology.
Case Study MICR Hematology Spring, 2011 Case # 5 Hee Jin Kim, Hooman Nikizad and Arthur Omuro.
Myeloproliferative Disorders (MPDs)
Myelofibrosis Chronic idiopathic myelofibrosis Progressive fibrosis of the marrow & increase connective tissue element Agnogenic myeloid metaplasia  Extramedullary.
Chronic leukemia 1. Chronic Lymphocytic leukemia (CLL) * Definition: Chronic neoplastic disorder characterized by accumulation of small mature-looking.
Chronic myeloid leukaemia (CML)
Dr Nauman Butt – Royal Liverpool University Hospital CML Patient Seminar - 14 th November 2015 What is CML? How do we treat it? Get up to speed…
MYELOPROLIFERATIVE DISEASES CHRONIC MYELOGENOUS LEUKAEMIA By DR. FATIMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
CHRONIC LEUKEMIA Dr. Hayam Hebah Associate professor of Internal Medicine AL Maarefa College.
Heterogeneous group of hematopoietic neoplasms Uncontrolled proliferation and decreased apoptotic activity with variable degrees of differentiation Composed.
..  Neoplastic proliferation of small mature appearing  lymphocytes and account 25% of leukemia  It is rare before 40 years of age, the median age.
MLAB Hematology Keri Brophy-Martinez
Acute Leukemia Kristine Krafts, M.D..
Myeloproliferative disorder Clonal evolution Clonal evolution & stepwise progression to fibrosis, marrow failure or acute blast phase.
Myeloproliferative Diseases Mark D. Browning, M.D. Oncology/Hematology Associates February 24, 2016.
Chronic Myeloid Leukemia
Case report Sudden blastic transformation in patient with chronic myeloid leukemia treated with imatinib mesylate Mehrdad Payandeh,MD Hematology, Medical.
LEUKEMIA Dr. Omar Alshaer. Acute Leukemia.
Acute lymphoblastic leukemia in children
AML Clinical Presentation. Clinical Presentation: Symptoms Fatigue (50%) Anorexia and weight loss Fever with or without an identifiable infection (10%)
골수증식 질환 Myeloproliferative disorders (MPD) [ 새로운 분류와 진단 기준 ] 경희의대 종양혈액내과 조 경 삼.
CHAPTER 7 DISORDERS OF BLOOD CELLS & VESSELS. HEMATOPOIESIS Generation of blood cells Lymphoid progenitor cells = lymphocytes (WBCs) Myeloid progenitor.
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives chronic myeloid leukaemia (CML) Haematopoietic malignancies Polycythemia vera (PV) Idiopathic myelofibrosis.
Chronic Myelocytic Leukemia Mark D. Browning, M.D. Oncology/Hematology Associates February 26, 2016.
Chronic myeloid leukaemia
Associate professor of Internal Medicine
Acute Leukemia Kristine Krafts, M.D..
MYELOPROLIFERATIVE DISEASES
LEUKEMIAS H.A. MWAKYOMA, MD.
Myeloproliferative disorder Clonal evolution Clonal evolution & stepwise progression to fibrosis, marrow failure or acute blast phase.
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
11 th lecture Chronic myeloid leukaemia By DR Fatehia Awny Faculty of Health Science Beirut Arab University
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
CHRONIC MYELOID LEUKEMIA (CML)
Associate professor of Internal Medicine
Case Study ….
Chronic Leukemia Kristine Krafts, M.D..
Acute leukemia.
CASE STUDY Leukemia.
Leukemia.
Lymphoid Preponderance and the Absence of Basophilia
A presentation By Abedelaziz Taha Hammash supervisor \ Mr
Case study A 36-year-old woman presented with a two-month history of increasing fatigue and abdominal fullness with accompanying loss of appetite. There.
Chronic Leukemia Dr. Noha Noufal.
CHRONIC LEUKEMIA BY: DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST
Presentation transcript:

Myeloprolifrative disorders -Chronic Myelogenouse Leukemia - Primary Poly Cythemia ( vira ) - Essential Thrombocythemia - Myelofibrose Myeloid Methaplasia

Chronic Myeloid leukemia Malignant disease of an early hemopoietic progenitor cell. The clonal marker is found in all three lineage : - erythroid - myeloid - megakaryocyte

‍Chronic Myelogeneuse Leukemia - >90% Ph phase of disease, Chronic, Accelatory, Acute. - May present with any phase. - Duration of chronic phase varies ( 3m -23y. Medium4.5 y - All cases eventually transform to blast crisis.

‍Clinical symptoms and signs in CML -Many patiente asymptomatic - Fatigue, Weight loss, Sweating,…….. - Splenomegaly may cause abdominal fullness. - Gout, bruising, spleen infarct, priapism. - Signs include Splenomegaly & Hepatomegaly. - Occasional Leucostatic signs at presentation.

Lab findings in CML: or 30 percent peripheral blood or bone marrow blasts 2- Large foci or clusters of blasts on the bone marrow biopsy. 3- Presence of extramedullary blastic infiltrates (eg, chloroma). These definitions become important for prognosis, particularly in patients considered for hematopoietic cell transplantation, in whom the outcome is better when transplantation is performed in the chronic phase.

Diagnosis and investigations of CML FBC & blood film (WBC high mainly Neutrophil & Myelocyte Platelets may be raised & clumped on film. ESR & N-APh score low in absence infection. LDH & Urate level are high BM gross Hypercellularity and Ph+ on chromosomal analysis. Blast count raises with blastic crisis transformation.

Other Philadelphia chromosome + ve malignancies : The majority of these patients exhibit a clinical course consistent with CML, including eventual progression to blast crisis, and probably represent CML with an atypical initial presentation. sensitive reverse transcriptase-polymerase chain reaction (RT-PCR) assays for detection of the BCR-ABL fusion mRNA have shown that this product can be detected at low levels in approximately 50 %of Ph-negative patients with E T ; the significance of BCR-ABL transcripts in this setting requires further investigation. - The Ph chromosome is found in 20 to 30 percent of adults with acute B-lymphoblastic leukemia. - 5 to 10 % of childhood B-ALL, and 1 to 2 % of adult AML. - The presence of the Ph chromosome in acute leukemia patients strongly correlates with a poor prognosis.

Treatment of CML - Incurable without stem cell Transplantation. -Hydroxturea in maintenance drug of choice (controling WBC) 1-1.5g po/d. rash, mouth ulcer and diarrhoea. -INF-a SC may produce cytogenetic response (reducing % +ve Ph cells). All patients on IFn-a have longer survival than Hydroxyurea.

Classification of Polycythemia -Essential Polycythemia -Hypoxic Polycythemia -Polycythemia due to high Epo. - Apparent polycythemia